top of page
Dr. Richard Matulewicz on the BackTable Urology Podcast

Dr. Richard Matulewicz

Urologic Oncologist

3 Podcasts • 1 Course on BackTable

Dr. Richard Matulewicz is a urologic oncologist and surgeon at Memorial Sloan Kettering Cancer Center in New York City.

Learn from the experiences and expertise of Dr. Richard Matulewicz and other leading voices in your specialty on the BackTable app.

Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 227  •  22 Apr 2025

Tumor Board: Multidisciplinary Management of Testicular Germ Cell Tumors

What does it take to deliver truly personalized, multidisciplinary care in testicular cancer? Get an inside look in this episode of BackTable Urology, where renowned testicular cancer experts Dr. Nabil Adra and Dr. Richard Matulewicz join host Dr. Aditya Bagrodia for a virtual tumor board session on the nuanced management of germ cell tumors. This episode was produced in collaboration with the Society of Urologic Oncology.

This podcast is supported by

Ferring Pharmaceuticals

More from Dr. Richard Matulewicz

Loading recent podcasts…

GU Tumor Board Cases

Urology Course

2.5 hours, 11 lessons

About

Dr. Richard Matulewicz is a Memorial Sloan Kettering Cancer Center fellowship-trained urologic oncologist and health services researcher with expertise in the open, robotic, and endoscopic surgical treatment of urologic cancers (testicular, kidney, bladder, and prostate). He received his medical degree from Tufts University School of Medicine. Dr. Matulewicz completed his residency at Northwestern followed by two fellowships in New York City. He has a particular interest in improving the way physicians diagnose and treat people with testicular cancer (germ cell tumors). He aims to accomplish this by rigorously studying the impact that various treatment strategies have on health-related quality of life, assessing new ways to integrate novel diagnostics such a micro-RNA into clinical practice, and understanding long-term outcomes of surgical treatments like retroperitoneal lymph node dissection (RPLND).

Visit Memorial Sloan Kettering Cancer Center to learn more about Dr. Richard Matulewicz.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page